Immune response Clinical Trials

12 recruitingLast updated: June 18, 2026

There are 12 actively recruiting immune response clinical trials across 7 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4. Top locations include Créteil, France, Ghent, Belgium, Grenoble, France. Updated daily from ClinicalTrials.gov.


Immune response Trials at a Glance

12 actively recruiting trials for immune response are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Créteil, Ghent, and Grenoble. Lead sponsors running immune response studies include Assistance Publique - Hôpitaux de Paris, Centre for Infectious Disease Research in Zambia, and Australian Government, Department of Defence (Defence Science and Technology Group, DMTC).

Browse immune response trials by phase

Treatments under study

About Immune response Clinical Trials

Looking for clinical trials for Immune response? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Immune response trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Immune response clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

How Gut Health Affects Immune Responses to the Oral Rotavirus Vaccine in Adults in Zambia

TranscriptomicsFeasibility StudyVaccine Immune Response+1 more
Centre for Infectious Disease Research in Zambia43 enrolled1 locationNCT07626606
Recruiting

Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals at Risk of Nephropathy

Immune responseBK polyomavirusBK Nephropathy+6 more
University Hospital, Grenoble100 enrolled1 locationNCT07347769
Recruiting

Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus

Hepatitis B vaccinationImmune responseT Cells
Assistance Publique - Hôpitaux de Paris115 enrolled1 locationNCT06876467
Recruiting

Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2

InfluenzaSARS-CoV-2 (COVID-19) InfectionImmune Response of Host
Washington University School of Medicine300 enrolled1 locationNCT06848309
Recruiting
Phase 2

Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study)

Colorectal, CancerColon CancerPerioperative Immune Response
Institute of Oncology Ljubljana100 enrolled1 locationNCT07432399
Recruiting
Phase 4

Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons

VaccinationTransgender PersonsMeningococcal Meningitis, Serogroup B+1 more
University Ghent250 enrolled1 locationNCT06832514
Recruiting
Not Applicable

Prebiotics (Dried Plum) and Immune Function in Postmenopausal Women

T Cell Response to Dried PlumVitamin D Influence on Immune ResponseDried Plum and Immune Function
Indiana University30 enrolled1 locationNCT07222111
Recruiting
Phase 1

Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine

Vaccine ResponseImmune Response to Covid 19 VaccinationCOVID-19 vaccine
The Methodist Hospital Research Institute75 enrolled1 locationNCT06821100
Recruiting
Not Applicable

Clinical Study on Intraluminal Injection of FOLactis

Immune responseSolid TumorPleural Effusion, Malignant+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School40 enrolled1 locationNCT06512896
Recruiting

Evaluation of the psychoneuroimmunological state of healthy humans following intramuscular injection of the influenza (FluQuadriTM) vaccine, a two-way crossover double-blinded placebo-controlled trial

Immune responsesPsychomotor impairment
Australian Government, Department of Defence (Defence Science and Technology Group, DMTC)40 enrolled1 locationACTRN12623000650695
Recruiting

Post-Vaccination Biological Collection

Immune responseVaccination
Assistance Publique - Hôpitaux de Paris1,200 enrolled1 locationNCT03875703
Recruiting

Bacille Calmette-Guérin (BCG) Immune Response Study

Immune response after BCG vaccineTuberculosis
The Mercy Hospital for Women256 enrolled1 locationACTRN12608000227392